UCB appoints UK & Ireland general manager

2 September 2024

Belgian drugmaker UCB (Euronext: UCB) has appointed Nico Reynders as general manager of its UK & Ireland affiliate.

In this role, he will lead the affiliate and work with UCB’s partners through a period of growth, ensuring continued pursuit of innovation to deliver medicines for people living with severe diseases.

Mr Reynders, who has worked for UCB for 14 years in a wide range of roles including periods in Shanghai, Brussels and Atlanta (USA), joins the UK & Ireland affiliate from the global bone health business based in Belgium, where he was responsible for development of the company’s bone health business worldwide.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK